Delivery Order SPE2DB24D3013-SPE2DB25FFQMF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg tablets (28-count packages) with a ceiling value of $3,229.90. The contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. Performance will take place at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,752,647 methylergonovine 0.2 mg tablets, with a total ceiling value of $1,443.24. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 2, 2025. AmerisourceBergen Drug Corp is the prime contractor on this award and does not have any...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.44 firm fixed-price contract is for the delivery of 4557734719 methylergonovine 0.2 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
- This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.62 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, an ergot alkaloid medication used primarily in obstetric settings. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQMFDelivery Order
This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The pharmaceutical prime vendor vehicle enables the company to deliver a comprehensive range of medications and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Methylergonovine is an ergot alkaloid medication used in obstetric care, reflecting the broad therapeutic portfolio the company supplies through its federal contracts, which span from specialized medications to vaccines and medical devices across multiple clinical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/11/25 |